Examining the utility of cystatin C as a confirmatory test of chronic kidney disease across the age range in middle-aged and older community-dwelling adults.

Mark CanneyDonal J SextonNeil O'LearyMartin HealyRose Anne KennyMark A LittleConall M O'Seaghdha

Published in: Journal of epidemiology and community health (2018)

The clinical utility of cystatin C may be maximised in middle-aged individuals, in whom the distribution of cystatin C is less variable than older adults, and the pretest probability of confirming CKD is lower.

Keyphrases

community dwelling
chronic kidney disease
middle aged
end stage renal disease
physical activity
peritoneal dialysis